Proteome Sciences (LON:PRM) Stock Price Up 3.4% – Here’s Why

Shares of Proteome Sciences plc (LON:PRM) rose 3.4% during trading on Friday . The stock traded as high as GBX 5 ($0.06) and last traded at GBX 4.64 ($0.06). Approximately 485,157 shares were traded during mid-day trading, an increase of 165% from the average daily volume of 183,230 shares. The stock had previously closed at GBX 4.49 ($0.06).

Proteome Sciences Trading Up 3.4 %

The company’s 50 day simple moving average is GBX 3.84 and its 200 day simple moving average is GBX 3.26. The company has a debt-to-equity ratio of -258.66, a current ratio of 0.20 and a quick ratio of 0.37. The firm has a market cap of £13.71 million, a price-to-earnings ratio of -3.36 and a beta of 0.07.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.